buyWeak10b5-1 plan
Scott Braunstein bought $6,526 of MRNS
CHAIRMAN AND CEO at MARINUS PHARMACEUTICALS, INC.. 5,933 shares at an average of $1.10, traded Aug 14, 2024, filed Feb 11, 2025.
Conviction score
10Value
$6,526
5,933 shares
Holdings after
304,600
+2% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +25RoleCEO
- 0Trade size$7k at market
- 0Relative to holdingsHoldings up 2.0%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
- -1510b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001104659-25-011239, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 14, 2024 | POpen-market purchase Common Stock10b5-1 | +5,933 | $1.10 | $6,526 | 304,600 | Feb 11, 2025 |
| Feb 7, 2025 | DDisposition to issuer Common Stock | -125,064 | $0.55 | $69k | 179,536 | Feb 11, 2025 |
| Feb 11, 2025 | DDisposition to issuer Common Stock | -179,536 | $0.55 | $99k | 0 | Feb 11, 2025 |
| Feb 11, 2025 | DDisposition to issuer Stock Option (Right to Buy)derivative | -167,825 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | DDisposition to issuer Stock Option (Right to Buy)derivative | -335,650 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | DDisposition to issuer Stock Option (Right to Buy)derivative | -360,000 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | DDisposition to issuer Stock Option (Right to Buy)derivative | -193,050 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | DDisposition to issuer Stock Option (Right to Buy)derivative | -290,000 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | DDisposition to issuer Stock Option (Right to Buy)derivative | -450,000 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | DDisposition to issuer Stock Option (Right to Buy)derivative | -200,000 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | DDisposition to issuer Stock Option (Right to Buy)derivative | -15,917 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 11, 2025 | DDisposition to issuer Stock Option (Right to Buy)derivative | -7,500 | $0.00 | $0 | 0 | Feb 11, 2025 |
Related signals
Other insiders at MARINUS PHARMACEUTICALS, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 8Weak | MARINUS PHARMACEUTICALS, INC. | Elan Ezickson director | $864 1,600 shares | -13% | |
| 8Weak | MARINUS PHARMACEUTICALS, INC. | Marvin Johnson director | $869 1,610 shares | -11% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.